Parkside Financial Bank & Trust’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1
Closed -$326 2123
2024
Q1
$326 Hold
1
﹤0.01% 1836
2023
Q4
$191 Sell
1
-1
-50% -$189 ﹤0.01% 1948
2023
Q3
$399 Buy
2
+1
+100% +$236 ﹤0.01% 1940
2023
Q2
$286 Buy
+1
New +$278 ﹤0.01% 1945
2022
Q4
Sell
-60
Closed -$17K 2063
2022
Q3
$17K Sell
60
-28
-32% -$7.12K 0.01% 866
2022
Q2
$17K Buy
+88
New +$15.5K 0.01% 864

Other funds holding SWAV

Parkside Financial Bank & Trust's SWAV Position: Q2 2024 in Review

Parkside Financial Bank & Trust sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 1 share — an estimated $326 sold.

Parkside Financial Bank & Trust first reported a position in SWAV in Q2 2022 and held it in 6 quarters. The position peaked at $17K in Q3 2022. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Parkside Financial Bank & Trust reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 1 Shockwave Medical, Inc. Common Stock share in Q2 2024, an estimated $326.
  • Parkside Financial Bank & Trust first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2022 and held it in 6 quarters.
  • Parkside Financial Bank & Trust's Shockwave Medical, Inc. Common Stock position peaked at $17K in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2024, filed 5 Aug 2024.